reports
MARA Announces Bitcoin Production and Mining Operation Updates for Mar...
MARA Announces Bitcoin Production and Mining Operation Updates for March 2025 242 Blocks Won in March, 17% Increase M/MIncreased BTC Holdings* to 47,531 BTC Fort Lauderdale, FL, April 03, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: ) ("MARA" or the "Company"), a global leader in leveraging digital asset compute to support energy transformation, today published unaudited bitcoin ("bitcoin" or "BTC") production updates for March 2025. Management Commentary"In March, our production saw a 17% month-over-month increase in blocks won, even as global hashrate and mining difficulty grew," said Fred Thie...
Glucotrack and OneTwo Analytics to Collaborate for Clinical Study Anal...
Glucotrack and OneTwo Analytics to Collaborate for Clinical Study Analysis on Its Continuous Blood Glucose Monitor Next Generation AI-Driven Analytics to Unlock Key Insights from the Ongoing Continuous Blood Glucose Monitoring Clinical Study Data RUTHERFORD, N.J. and STOCKHOLM, April 03, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK), a medical device company focused on the design, development, and commercialization of novel technologies for people with diabetes, today announced an agreement with OneTwo Analytics AB, a leading healthtech company specializing in AI-driven analy...
Elutia to Participate in Upcoming Investor Conferences
Elutia to Participate in Upcoming Investor Conferences SILVER SPRING, Md., April 03, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia”), a pioneer in drug-eluting biomatrix technologies, today announced that Dr. Randy Mills, President and Chief Executive Officer, and Matt Ferguson, Chief Financial Officer, will participate in the following upcoming investor conferences: LD Micro 15th Annual Invitational – New York, NYFormat: Presentation and 1x1 Meetings Presentation Date and Time: Thursday, April 10, 2025, 12:30 p.m. ET (9:30 a.m. PT)Webcast: Planet Microcap Showcase – Las...
Phathom Pharmaceuticals to Present at the 24th Annual Needham Virtual ...
Phathom Pharmaceuticals to Present at the 24th Annual Needham Virtual Healthcare Conference FLORHAM PARK, N.J., April 03, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, announced today that members of the management team will participate in a fireside chat at the 24th Annual Needham Virtual Healthcare Conference on Tuesday, April 8th, 2025, at 10:15 am ET. Company management will also participate in one-on-one meetings during the conference, w...
Puravankara Ltd: 1 director
A director at Puravankara Ltd sold 12,000 shares at 248.926INR and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearl...
Ecofirst Consolidated Bhd: 1 director
A director at Ecofirst Consolidated Bhd bought 5,000,000 shares at 0.405MYR and the significance rating of the trade was 62/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two...
Spotify Technology S A: 1 director
A director at Spotify Technology S A sold 50,000 shares at 551.730USD and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two year...
Love on Tap: Heineken® Launches Dating App for Bars to Help Young Adul...
Love on Tap: Heineken® Launches Dating App for Bars to Help Young Adults Spice Up Their Social Lives Heineken® has unveiled apps in Italy and Brazil that will help young adults find bars the same way they prefer to find love: through swipingGlobal data shows that 67% of young adults* tend to go back to the same bar time again, despite wanting now more than ever to explore new places, have new experiences and meet new peopleWith dating apps now part of everyday life, Heineken® is blending the words of swiping and socialising - offering consumers a clever and easy new way to match with a new ...
Pacira BioSciences Announces First Patient Dosed in Phase 2 Study Eval...
Pacira BioSciences Announces First Patient Dosed in Phase 2 Study Evaluating Safety and Efficacy of PCRX-201 for the Treatment of Osteoarthritis of the Knee -- Novel, locally administered gene therapy designed to boost cellular production of anti-inflammatory protein IL-1Ra in the knee -- -- Initial topline results from two-part, randomized, double-blind, active-controlled study expected late 2026 -- BRISBANE, Calif., April 03, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies ...
Vera Therapeutics Completes Full Enrollment in Pivotal ORIGIN Phase 3 ...
Vera Therapeutics Completes Full Enrollment in Pivotal ORIGIN Phase 3 Trial for Atacicept in IgAN On track to announce primary endpoint result from ORIGIN 3 trial this quarter (2Q 2025)U.S. FDA BLA submission for accelerated approval planned for 2H 2025 BRISBANE, Calif., April 03, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today announced that it has completed full enrollment in the pivotal ORIGIN Phase 3...
Northern Technologies International Corporation to Announce Fiscal 202...
Northern Technologies International Corporation to Announce Fiscal 2025 Second-Quarter Financial Results and Host Conference Call MINNEAPOLIS, April 03, 2025 (GLOBE NEWSWIRE) -- Northern Technologies International Corporation (NASDAQ: NTIC) today announced that it expects to release its fiscal 2025 second-quarter financial results on Thursday, April 10, 2025, before the market opens. A copy of the news release will be available on the Investor Relations section of NTIC’s webpage (). In conjunction with NTIC’s release of its financial and operating results, investors, analysts, and other ...
Akebia Therapeutics Announces Positive Opinion of European Medicines A...
Akebia Therapeutics Announces Positive Opinion of European Medicines Agency for XOANACYL®, an Oral Therapy for Chronic Kidney Disease Licensed to Averoa CAMBRIDGE, Mass., April 03, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending the European Commission (EC) to approve XOANACYL® (Ferric Citrate as Coordination Complex) for the treatmen...
SINTX Technologies Announces Strategic Changes to Board of Directors
SINTX Technologies Announces Strategic Changes to Board of Directors Company positions for long-term growth in medical device markets Salt Lake City, UT, April 03, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT), an advanced ceramics company focused on medical device applications, today announced changes to its Board of Directors. The updates reflect the Company’s ongoing strategic transformation into a focused medical technology business. Key changes include the retirement of longtime Chairman Dr. B. Sonny Bal, the appointment of President and CEO Eric Olson as Chairma...
Greenwich LifeSciences Provides Global Update on FLAMINGO-01
Greenwich LifeSciences Provides Global Update on FLAMINGO-01 STAFFORD, Texas, April 03, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences, today provided the following global update on FLAMINGO-01. Flamingo-01 Progress to Date & Future Plans The Company recently confirmed that the preliminary HLA prevalence, safety, and immune response data in FLAMINGO-01 patients is trendi...
Genius Group Blocked from Raising Funds and Buying Bitcoin by New York...
Genius Group Blocked from Raising Funds and Buying Bitcoin by New York Court SINGAPORE, April 03, 2025 (GLOBE NEWSWIRE) -- (NYSE American: GNS) (“Genius Group” or the “Company”), a leading AI-powered, Bitcoin-first education group, today announced that it is being forced to sell its Bitcoin Treasury after having been blocked from selling shares or raising funds, and specifically from using investor funds to buy Bitcoin by the United States District Court Southern District of New York (SDNY). As previously reported by the Company, on October 30, 2024 Genius initiated arbitration procedur...
Good Earth Oils Canola Oil Now Available on JD.com
Good Earth Oils Canola Oil Now Available on JD.com COOTAMUNDRA, Australia, April 03, 2025 (GLOBE NEWSWIRE) -- Australian Oilseeds Holdings Limited, a Cayman Islands exempted company (the “Company”) (NASDAQ: COOT) today announced Good Earth Oils (GEO) premium quality canola oil has successfully entered the JD.com supply chain and is now available for purchase on JD.com’s self-operated platform. “This milestone marks another significant advancement for GEO’s presence in the Chinese market,” said Gary Seaton, Chief Executive Officer. “By joining JD.com’s self-operated platform, GEO enhanc...
TerrAscend to Host First Quarter 2025 Earnings Conference Call
TerrAscend to Host First Quarter 2025 Earnings Conference Call TORONTO, April 03, 2025 (GLOBE NEWSWIRE) -- TerrAscend Corp. ("TerrAscend" or the "Company") (TSX: TSND) (OTCQX: TSNDF), a leading North American cannabis company, today announced that it will host a scheduled conference call to discuss the results for its first quarter ended March 31, 2025 on Thursday, May 8, 2025 at 5:00 p.m. Eastern Time. The Company will report its financial results for the first quarter 2025 the same day after market close. CONFERENCE CALL DETAILS Date:Thursday, May 8, 2025Time:5:00 p.m. Eastern TimeWeb...
CRISPR Therapeutics to Present at the 24th Annual Needham Virtual Heal...
CRISPR Therapeutics to Present at the 24th Annual Needham Virtual Healthcare Conference ZUG, Switzerland and BOSTON, April 03, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced that members of its senior management team will present at the 24th Annual Needham Virtual Healthcare Conference on Tue, April 8 at 12:45 p.m. ET. A live webcast of the fireside chat will be available on the "Events & Presentations" page in the Investors section of the Company's webs...
aTyr Pharma to Participate in April Investor Conferences
aTyr Pharma to Participate in April Investor Conferences SAN DIEGO, April 03, 2025 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform, today announced that the company will participate in two upcoming investor conferences scheduled to take place in April 2025. Details of the conferences appear below: Conference: Jones Healthcare and Technology Innovation Conference Date: April 8 – 9, 2025Location: Las Vegas, NVFormat: 1x1 Invest...
MoneyHero Group to Announce Fourth Quarter and Full Year 2024 Results
MoneyHero Group to Announce Fourth Quarter and Full Year 2024 Results SINGAPORE, April 03, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: ) (“MoneyHero” or the “Company”), a leading personal finance aggregation and comparison platform, as well as a digital insurance brokerage provider in Greater Southeast Asia, today announced that it will release its fourth quarter and full year 2024 results on Tuesday, April 29, 2025 before market opens and will hold a related conference call to discuss the results at 8:00 a.m. EDT the same day. Investors and other interested parties may listen to the call by ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.